• Aptamer-based COVID-19 diagnostics

Aptamer Group advances COVID-19 testing capabilities with Integumen

Aptamer Group Ltd, the developer of diagnostic and therapeutic aptamer reagents, is pleased to announce further progress in their collaboration with Integumen plc (AIM: SKIN) to develop Microtox PD, a wastewater detection system for COVID-19. Aptamer Group is also collaborating with Integumen on the development of a new personalised rapid COVID-19 breath test, Microtx BT, […]

Aptamer Group and Cytiva form new collaboration for the development of COVID-19 Rapid Test

Collaboration to produce a rapid test for the COVID-19 coronavirus infection
Aptamer Group, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The company will use its recently developed aptamer reagent combined with Cytiva’s lateral flow technology to produce a Lateral Flow Device (LFD)*. Aptamer […]

Aptamer Group making headlines on their Point of Care COVID19 reagent developments

 
Arron Tolley, CEO of Aptamer Group discusses the teams progress on COVID19 tests:
 

https://www.linkedin.com/feed/update/urn:li:activity:6678971478534324225